Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
J. Reeve(Nuffield Orthopaedic Centre), John T. Potts(Harvard University), O. L. M. Bijvoet, F. J. F. E. Vismans, Pierre J. Meunier(Unknown), J C Rénier, C Edouard(Laboratoire d'Hydrodynamique de l'École polytechnique), M Bernat, Robert M. Neer(Brigham and Women's Hospital), J. A. Parsons, P Courpron, L. Klenerman(University of Liverpool), David M. Slovik(Unknown)
Cited by 585
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
|New England Journal of Medicine|2012|809
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
|The Lancet|2015|574
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
|The Lancet|2013|491
Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients
|New England Journal of Medicine|1981|372